Sustained Low Clinical Event Rates in Real-World Patients Receiving Everolimus-Eluting Coronary Stent System from a Large, Prospective, Condition of Approval Study: 2-Year Clinical Outcomes from the XIENCE V®USA Study: THE XIENCE V®USA STUDY: 2-YEAR REAL-WORLD OUTCOMES OF EECSS